Targeting Tryptophan Catabolism in Ovarian Cancer to Attenuate Macrophage Infiltration and PD-L1 Expression
Lyndsey S. Crump(University of Colorado Cancer Center), Benjamin G. Bitler(University of Colorado Denver)
Cited by 21
Related Papers
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer
|Oncogenesis|2018|86
Hormonal Regulation of Semaphorin 7a in ER+ Breast Cancer Drives Therapeutic Resistance
|Cancer Research|2020|44
Targeting DUSP Activity as a Treatment for High-Grade Serous Ovarian Carcinoma
|Molecular Cancer Therapeutics|2022|21
Loss of Claudin-4 Reduces DNA Damage Repair and Increases Sensitivity to PARP Inhibitors
|Molecular Cancer Therapeutics|2022|17
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation
|Molecular Cancer Therapeutics|2024|11